Cargando…

Enzyme Activity in Relation to Cancer: The Urinary β-Glucuronidase Activity of Patients Suffering from Malignant Disease

Detalles Bibliográficos
Autores principales:	Boyland, E., Gasson, J. E., Williams, D. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1957
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073923/ https://www.ncbi.nlm.nih.gov/pubmed/13436707

Ejemplares similares

Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds
por: Boyland, E., et al.
Publicado: (1957)

The Activity of the Enzymes Sulphatase and β-Glucuronidase in the Urine, Serum and Bladder Tissue
por: Boyland, E., et al.
Publicado: (1955)

Urinary β-Glucuronidase Activity in Cancer of the Bladder and other Diseases
por: Lewis, F. J. W., et al.
Publicado: (1960)

The Origin of Urinary β-Glucuronidase
por: Fripp, P. J.
Publicado: (1965)

Variation of β-Glucuronidase Levels within the C(3)H Strain and Observations on the Effect of Polycyclic Hydrocarbons on Glucuronidase Activity
por: Hamer, D.
Publicado: (1958)

Plasma β-Glucuronidase Levels in Breast Cancer
por: Whitaker, B. L.
Publicado: (1960)

Some Investigations into the Origin of the β-Glucuronidase Activity in the Urine of Patients with Cancer of the Bladder
por: Haije, W. G., et al.
Publicado: (1962)

Therapeutic significance of β-glucuronidase activity and its inhibitors: A review
por: Awolade, Paul, et al.
Publicado: (2020)

Monitoring glycosidase activity for clustered sugar substrates, a study on β-glucuronidase
por: Brissonnet, Yoan, et al.
Publicado: (2019)

Phenoxyacetohydrazide Schiff Bases: β-Glucuronidase Inhibitors
por: Jamil, Waqas, et al.
Publicado: (2014)

Microbial β-glucuronidases drive human periodontal disease etiology
por: Lietzan, Adam D., et al.
Publicado: (2023)

Assessment of gut microbial β-glucuronidase and β-glucosidase activity in women with polycystic ovary syndrome
por: Patel, Jalpa, et al.
Publicado: (2023)

Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
por: Bhatt, Aadra P., et al.
Publicado: (2020)

Estimation of salivary β-glucuronidase activity as a marker of periodontal disease: A case control study
por: Prabhahar, Chandra Sekhara, et al.
Publicado: (2014)

Cinnamic acid derivatives: inhibitory activity against Escherichia coli β-glucuronidase and structure–activity relationships
por: Li, Xing-Nuo, et al.
Publicado: (2020)

The Role of Gut Microbial β-Glucuronidase in Estrogen Reactivation and Breast Cancer
por: Sui, Yue, et al.
Publicado: (2021)

In-Silico Characterization of Estrogen Reactivating β-Glucuronidase Enzyme in GIT Associated Microbiota of Normal Human and Breast Cancer Patients
por: Muccee, Fatima, et al.
Publicado: (2022)

Extracellular vesicles protect glucuronidase model enzymes during freeze-drying
por: Frank, Julia, et al.
Publicado: (2018)

Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe
por: Chen, Michael, et al.
Publicado: (2017)

Native Electrophoresis-Coupled Activity Assays Reveal Catalytically-Active Protein Aggregates of Escherichia coli β-Glucuronidase
por: Burchett, Gina G., et al.
Publicado: (2015)

A High Throughput Assay for Discovery of Bacterial β-Glucuronidase Inhibitors
por: Ahmad, Syed, et al.
Publicado: (2011)

Glucuronidase Activity Of Escherichia Coli Isolated From Chicken Carcasses
por: Martins Perin, Luana, et al.
Publicado: (2010)

HISTOLOGY AND CYTOCHEMISTRY OF HUMAN SKIN : XI. THE DISTRIBUTION OF β-GLUCURONIDASE
por: Montagna, William
Publicado: (1957)

A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target
por: Fernández-Murga, M. Leonor, et al.
Publicado: (2023)

Plasma β-Glucuronidase as an Index of Hormone Dependency of Breast Tumours
por: Whitaker, B. L.
Publicado: (1961)

Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn’s Disease Patients and Unaffected First-Degree Relatives
por: Gloux, Karine, et al.
Publicado: (2016)

β-Glucuronidase activity and mitochondrial dysfunction: the sites where flavonoid glucuronides act as anti-inflammatory agents
por: Kawai, Yoshichika
Publicado: (2014)

Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity
por: Taylor, Michael R., et al.
Publicado: (2019)

Glucuronides Hydrolysis by Intestinal Microbial β-Glucuronidases (GUS) Is Affected by Sampling, Enzyme Preparation, Buffer pH, and Species
por: Ebuzoeme, Christabel, et al.
Publicado: (2021)

A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase
por: Besse, Helena C., et al.
Publicado: (2020)

Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception
por: Pellock, Samuel J., et al.
Publicado: (2018)

Chemical Constituent of β-Glucuronidase Inhibitors from the Root of Neolitsea acuminatissima
por: Lin, Chu-Hung, et al.
Publicado: (2020)

Soy Saponins Meditate the Progression of Colon Cancer in Rats by Inhibiting the Activity of β-Glucuronidase and the Number of Aberrant Crypt Foci but Not Cyclooxygenase-2 Activity
por: Guo, Yu-Wei, et al.
Publicado: (2013)

Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors
por: Yousuf, Maria, et al.
Publicado: (2018)

Draft Genome Sequences of Buttiauxella spp. Isolates from Water and Gastropods with Putative β-d-Glucuronidase Activity
por: Leister, Carolin, et al.
Publicado: (2022)

Author Correction: Extracellular vesicles protect glucuronidase model enzymes during freeze-drying
por: Frank, Julia, et al.
Publicado: (2019)

Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity
por: Palko-Łabuz, Anna, et al.
Publicado: (2021)

A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.
por: Haisma, H. J., et al.
Publicado: (1992)

Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli β-glucuronidase inhibitors and their structure–inhibitory activity relationships
por: Zhou, Tao-Shun, et al.
Publicado: (2020)

New planar assay for streamlined detection and quantification of β-glucuronidase inhibitors applied to botanical extracts
por: Mahran, Ehab, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_norjgsuoeu6odtp303hf7j83oc